{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T10:10:04Z","timestamp":1756289404589,"version":"3.44.0"},"reference-count":6,"publisher":"BMJ","issue":"2","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2024,2,12]]},"published-print":{"date-parts":[[2024,2]]},"abstract":"<jats:p>This report describes a case of a patient with active multiple myeloma who was started on bortezomib, cyclophosphamide and dexamethasone and subsequently presented to the emergency department with acute intestinal obstruction one week later. The patient underwent exploratory laparotomy, but no mechanical cause of the obstruction was found. The patient later developed sepsis and eventually died. The possible cause of the intestinal obstruction was attributed to bortezomib, and the paper discusses the potential mechanism of this side effect and its management based on available literature.<\/jats:p>","DOI":"10.1136\/bcr-2023-257592","type":"journal-article","created":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T12:50:28Z","timestamp":1708519828000},"page":"e257592","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Possible case of bortezomib-induced ileus paralytic"],"prefix":"10.1136","volume":"17","author":[{"given":"Nikhil","family":"Aravind","sequence":"first","affiliation":[{"name":"Pharmacology, Post Graduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niveditha","family":"Krishnappa","sequence":"additional","affiliation":[{"name":"Pharmacology, Post Graduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nusrat","family":"Shafiq","sequence":"additional","affiliation":[{"name":"Pharmacology, Post Graduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pankaj","family":"Malhotra","sequence":"additional","affiliation":[{"name":"Hematology, Internal Medicine, PGIMER, Chandigarh, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2024,2,21]]},"reference":[{"key":"2025082702505045000_17.2.e257592.1","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2016-217000","article-title":"Strategy to reduce bortezomib-induced paralytic Ileus in patients with myeloma and impaired renal function","volume":"2016","author":"Keating","year":"2016","journal-title":"BMJ Case Rep"},{"key":"2025082702505045000_17.2.e257592.2","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s10238-015-0337-6","article-title":"\u201cParalytic Ileus following \u201csubcutaneous bortezomib\u201d therapy: focus on the clinical emergency-report of two cases\u201d","volume":"16","author":"Mele","year":"2016","journal-title":"Clin Exp Med"},{"key":"2025082702505045000_17.2.e257592.3","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1182\/blood.2020005288","article-title":"Daratumumab, Lenalidomide, bortezomib, and dexamethasone for transplant-eligible newly diagnosed multiple myeloma: the GRIFFIN trial","volume":"136","author":"Voorhees","year":"2020","journal-title":"Blood"},{"key":"2025082702505045000_17.2.e257592.4","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(19)30152-4"},{"key":"2025082702505045000_17.2.e257592.5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)31240-1"},{"key":"2025082702505045000_17.2.e257592.6","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.154"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2023-257592","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T09:51:00Z","timestamp":1756288260000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2023-257592"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":6,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,2,21]]},"published-print":{"date-parts":[[2024,2]]}},"alternative-id":["10.1136\/bcr-2023-257592"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2023-257592","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2024,2]]}}}